A Hybrid Deep Learning Approach for Diagnosis of the Erythemato-Squamous Disease [PDF]
2020 IEEE International Conference on Electronics, Computing and
Communication Technologies (CONECCT), 2019 The diagnosis of the Erythemato-squamous disease (ESD) is accepted as a difficult problem in dermatology. ESD is a form of skin disease. It generally causes redness of the skin and also may cause loss of skin. They are generally due to genetic or environmental factors.
arxiv +1 more source
Pityriasis following COVID-19 vaccinations: a systematic review
Dermatology Reports, 2023 In the wake of a global COVID-19 pandemic, where innovations in vaccination technology and the speed of development and distribution have been unprecedented, a wide variety of post-vaccination cutaneous reactions have surfaced.
Laura Duzett +4 more
doaj +1 more source
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™) [PDF]
, 2011 Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors.
Cho, Ah Young +5 more
core +2 more sources
Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study
Acta Dermato-Venereologica, 2019 Pityriasis rosea is a common acute exanthema of unknown aetiology, which causes severe anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our clinic between 2013 and 2017, were prospectively recorded. The patients
Mavişe Yüksel
doaj +1 more source
Anetodermic lesions following pityriasis rosea and impetigo [PDF]
, 2018 C. Moltrasio +3 more
core +2 more sources
Learning differential diagnosis of erythemato-squamous diseases using voting feature intervals [PDF]
, 1998 Cataloged from PDF version of article.A new classification algorithm, called VFI5 (for Voting Feature Intervals), is developed and applied to problem of differential diagnosis of erythemato-squamous diseases.
Demiroz, G., Guvenir, H. A., Ilter, N.
core +1 more source
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review [PDF]
, 2022 To date, over 250 million people have been reportedly infected by COVID-19 disease, which has spread across the globe and led to approximately 5.1 million fatalities.
Avallone, Gianluca +6 more
core +1 more source
Six cases of pityriasis rosea following SARS‐CoV‐2 vaccination with BNT162b2
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022 The development of vaccines against SARS-CoV-2 has been extremely quick [1–6], and currently the Moderna mRNA1273, Pfizer/BioNTech BNT162b2 mRNA, and the AstraZeneca/University of Oxford ChAdOx1-nCoV-19 chimpanzee adenovirus (ChAd) vector vaccines have ...
Y. Ramot +5 more
semanticscholar +1 more source
Atypical pityriasis rosea in a young Colombian woman. Case report
Case Reports, 2021 Introduction: Pityriasis rosea is an acute and self-limited exanthem first described by Gilbert in 1860. Its treatment is symptomatic, and although there is no conclusive evidence, it has been associated with the reactivation of the human herpesviruses ...
Julián Felipe Porras-Villamil +3 more
doaj +1 more source
Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study [PDF]
, 2022 Objectives In this study covering all of Turkey, we aimed to define cutaneous and systemic adverse reactions in our patient population after COVID-19 vaccination with the Sinovac/CoronaVac (inactivated SARS-CoV-2) and Pfizer/BioNTech (BNT162b2) vaccines.
Aktaş, Nurhan Döner +6 more
core +1 more source